Paracetamol versus ibuprofen as required for fever or pain in the first year of life and the risk of eczema and bronchiolitis at age 1 year in New Zealand (PIPPA Tamariki): a multicentre, open-label, parallel-group, superiority, randomised controlled trial

The Lancet Child & Adolescent Health 2026

View at publisher
Authors: Eunicia Tan, Christopher J D McKinlay, Judith Riley, Medhawani Rao, Lisa Mravicich, Shirley Lawrence, Allie Eathorne, Irene E. Braithwaite, Alex C. Semprini, Karaponi Okesene-Gafa, Nicolette Sheridan, Karen Hoare
+5 more Cameron Grant, David J. Johnson, Mark Weatherall, Richard Beasley, Stuart R Dalziel
DOI: 10.1016/s2352-4642(25)00341-4
Cited by: 1
References: 25

Fields of Study & Subjects

Thermal Regulation in Medicine Respiratory viral infections research Cardiovascular Conditions and Treatments

Publication details

Journal / source
The Lancet Child & Adolescent Health
Publisher
Elsevier BV
Volume
10
Issue
3
Pages
156–166
Publication date
27 January 2026
Language
EN